ENDOGEN ApS: Financial statements 2025
CVR: 29813337
Source: annual report 2025, Danish Business Authority
27/10/2024 – 26/10/2025
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428. The company had 1 employee in the financial year.
- Gross Profit
- DKK 113,212
- Profit/Loss
- DKK -79,499
- Equity
- DKK -82,428
- Total Assets
- DKK 145,402
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 113 t. | -79 t. | -82 t. | 1 |
| 2024 | - | -15 t. | -23 t. | -3 t. | 1 |
| 2023 | - | -19 t. | -19 t. | 20 t. | 1 |
| 2022 | - | -15 t. | -15 t. | 39 t. | 1 |
| 2021 | - | -23 t. | -24 t. | 54 t. | 1 |
Official annual report
How creditworthy is ENDOGEN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ENDOGEN ApS has published its annual report for 2024. Gross profit came to DKK -15,349, and the net result was DKK -22,939.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.